theodi/ndl-core-corpus huggingface dataset:
Epilepsy12 2019-20 clinical audit data
Source: data.gov.uk (2023-03-28)

Epilepsy12 2021 National organisational and clinical audits - combined report on 2020 data. This is a combined report of the organisational and clinical audits for Round 3 Cohort 2, published in 2021. 

Epilepsy12, the UK collaborative clinical audit of health care for children and young people with suspected epileptic seizures is a national clinical audit delivered by the Royal College of Paediatrics and Child Health. It is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England and the Welsh Government. Round 3 began on 1 April 2017 as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP).

The results are of the organisation of paediatric epilepsy services for children and young people in England and Wales as described at November 2020, and the standard of clinical care provided by services that focuses on patients in ‘cohort 2’. This is children and young people who had a first paediatric assessment for a ‘paroxysmal episode’ (or episodes) between 1 December 2018 and 30 November 2019. 

These data should not be interpreted without referring to the combined reports summary and Appendices A&G that contain the reports' full results. which is available at: https://www.rcpch.ac.uk/resources/epilepsy12-national-organisational-audit-clinical-audit-2021
Epilepsy12 2020 Organisational audit data
Source: data.gov.uk (2023-03-28)

Epilepsy12 2021 National organisational and clinical audits - combined report on 2020 data. This is a combined report of the organisational and clinical audits for Round 3 Cohort 2, published in 2021. 

Epilepsy12, the UK collaborative clinical audit of health care for children and young people with suspected epileptic seizures is a national clinical audit delivered by the Royal College of Paediatrics and Child Health. It is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England and the Welsh Government. Round 3 began on 1 April 2017 as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP).

The results are of the organisation of paediatric epilepsy services for children and young people in England and Wales as described at November 2020, and the standard of clinical care provided by services that focuses on patients in ‘cohort 2’. This is children and young people who had a first paediatric assessment for a ‘paroxysmal episode’ (or episodes) between 1 December 2018 and 30 November 2019. 

These data should not be interpreted without referring to the combined reports summary and Appendices A&G that contain the reports' full results. which is available at: https://www.rcpch.ac.uk/resources/epilepsy12-national-organisational-audit-clinical-audit-2021
State of the Nation Report Data Tables, January 2024
Source: data.gov.uk (2024-01-25)

National Oesophago-Gastric Cancer Audit (NOGCA) State of the Nation Report, January 2024. The National Oesophago-Gastric Cancer Audit evaluates the quality of care given to people with oesophago-gastric (OG) cancer in England and Wales, and people with oesophageal high grade dysplasia (HGD) in England. The audit aims to support NHS services to improve the quality of care delivered to these patients.

The National Oesophago-Gastric Cancer Audit is a collaborative, national clinical audit run by the Association of Upper Gastrointestinal Surgery of Great Britain & Ireland (AUGIS), British Society of Gastroenterology (BSG), Royal College of Radiologists, NHS England, and the National Cancer Audit Collaborating Centre at the Clinical Effectiveness Unit of the Royal College of Surgeons of England. The audit is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP), that is managed by the Healthcare Quality Improvement Partnership.

The NOGCA data file contains the results published within the January 2024 State of the Nation Report for English NHS trusts and Welsh health boards. The organisational figures are based on data from patients diagnosed with OG cancer or HGD up to 31 March 2022.

The data file contains information on: • Audit participation by NHS organisation and data completeness for the key fields. • Measures about the process of care given to patients. • Information about care outcomes and treatment.

These data files do not contain individual patient information, nor do they contain any patient identifiable data.
State of the Nation Report Organisation Data Viewer, January 2024
Source: data.gov.uk (2024-01-25)

National Oesophago-Gastric Cancer Audit (NOGCA) State of the Nation Report, January 2024. The National Oesophago-Gastric Cancer Audit evaluates the quality of care given to people with oesophago-gastric (OG) cancer in England and Wales, and people with oesophageal high grade dysplasia (HGD) in England. The audit aims to support NHS services to improve the quality of care delivered to these patients.

The National Oesophago-Gastric Cancer Audit is a collaborative, national clinical audit run by the Association of Upper Gastrointestinal Surgery of Great Britain & Ireland (AUGIS), British Society of Gastroenterology (BSG), Royal College of Radiologists, NHS England, and the National Cancer Audit Collaborating Centre at the Clinical Effectiveness Unit of the Royal College of Surgeons of England. The audit is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP), that is managed by the Healthcare Quality Improvement Partnership.

The NOGCA data file contains the results published within the January 2024 State of the Nation Report for English NHS trusts and Welsh health boards. The organisational figures are based on data from patients diagnosed with OG cancer or HGD up to 31 March 2022.

The data file contains information on: • Audit participation by NHS organisation and data completeness for the key fields. • Measures about the process of care given to patients. • Information about care outcomes and treatment.

These data files do not contain individual patient information, nor do they contain any patient identifiable data.
State of the Nation Report Composite Indicator, January 2024
Source: data.gov.uk (2024-01-25)

National Oesophago-Gastric Cancer Audit (NOGCA) State of the Nation Report, January 2024. The National Oesophago-Gastric Cancer Audit evaluates the quality of care given to people with oesophago-gastric (OG) cancer in England and Wales, and people with oesophageal high grade dysplasia (HGD) in England. The audit aims to support NHS services to improve the quality of care delivered to these patients.

The National Oesophago-Gastric Cancer Audit is a collaborative, national clinical audit run by the Association of Upper Gastrointestinal Surgery of Great Britain & Ireland (AUGIS), British Society of Gastroenterology (BSG), Royal College of Radiologists, NHS England, and the National Cancer Audit Collaborating Centre at the Clinical Effectiveness Unit of the Royal College of Surgeons of England. The audit is part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP), that is managed by the Healthcare Quality Improvement Partnership.

The NOGCA data file contains the results published within the January 2024 State of the Nation Report for English NHS trusts and Welsh health boards. The organisational figures are based on data from patients diagnosed with OG cancer or HGD up to 31 March 2022.

The data file contains information on: • Audit participation by NHS organisation and data completeness for the key fields. • Measures about the process of care given to patients. • Information about care outcomes and treatment.

These data files do not contain individual patient information, nor do they contain any patient identifiable data.
Epilepsy12 2021 Organisational audit data; Version 2
Source: data.gov.uk (2023-03-28)

Epilepsy12 2022 National organisational and clinical audits - combined report on 2021 data. This is a combined report of the organisational and clinical audits for Round 3 Cohort 3, published in 2022.

Epilepsy12, the UK collaborative clinical audit of health care for children and young people with suspected epileptic seizures is a national clinical audit delivered by the Royal College of Paediatrics and Child Health. It is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England and the Welsh Government. Round 3 began on 1 April 2017 as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP).

The results are of the organisation of paediatric epilepsy services for children and young people in England and Wales as described at November 2021, and the standard of clinical care provided by services that focuses on patients in ‘cohort 3’. This is children and young people who had a first paediatric assessment for a ‘paroxysmal episode’ (or episodes) between 1 December 2019 and 30 November 2020.

These data should not be interpreted without referring to the combined reports summary and Appendices A&G that contain the reports' full results. which is available at: https://www.rcpch.ac.uk/resources/epilepsy12-national-organisational-audit-clinical-audit-2022
Epilepsy12 round 3 cohort 3 clinical audit data; Version 2
Source: data.gov.uk (2023-03-28)

Epilepsy12 2022 National organisational and clinical audits - combined report on 2021 data. This is a combined report of the organisational and clinical audits for Round 3 Cohort 3, published in 2022.

Epilepsy12, the UK collaborative clinical audit of health care for children and young people with suspected epileptic seizures is a national clinical audit delivered by the Royal College of Paediatrics and Child Health. It is commissioned by the Healthcare Quality Improvement Partnership (HQIP) and funded by NHS England and the Welsh Government. Round 3 began on 1 April 2017 as part of the National Clinical Audit and Patient Outcomes Programme (NCAPOP).

The results are of the organisation of paediatric epilepsy services for children and young people in England and Wales as described at November 2021, and the standard of clinical care provided by services that focuses on patients in ‘cohort 3’. This is children and young people who had a first paediatric assessment for a ‘paroxysmal episode’ (or episodes) between 1 December 2019 and 30 November 2020.

These data should not be interpreted without referring to the combined reports summary and Appendices A&G that contain the reports' full results. which is available at: https://www.rcpch.ac.uk/resources/epilepsy12-national-organisational-audit-clinical-audit-2022